We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Caliper Technologies to Acquire Zymark

By Biotechdaily staff writers
Posted on 18 Jun 2003
In a move to add to the company's portfolio of laboratory automation products, Caliper Technologies Corp. More...
(Mountain View, CA, USA) has agreed to acquire Zymark Corp. (Hopkinton, MA, USA) for about US$57 million and 3.15 million shares of Caliper stock.

Zymark is a leading provider of laboratory automation, liquid handling, and robotics solutions for the life sciences, biotechnology, and pharmaceutical industries. The company's 2002 revenues were $65.4 million. Upon closing, Zymark will become a wholly owned subsidiary of Caliper, and will continue to sell products under its own name. The acquisition will integrate Zymark's liquid handling and automation solutions with Caliper's microfluidic technologies and LabChip expertise, resulting in a comprehensive portfolio of laboratory automation products for accelerating drug discovery and development.

"We have been aggressively looking for a value-creating acquisition as compelling as this one, that will drive the future success of our company and create significant benefit for our shareholders,” said James L. Knighton, president and CFO of Caliper. "This acquisition is expected to be immediately accretive to Caliper.”






Related Links:
Caliper
Zymark

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.